Indeed, the potential implications of these newly discovered downstream regulators from the TGF-β1 signaling in the fibrotic TME are still largely unknown, and further investigation may identify their pathogenic roles in the fibrotic microenvironment as well as the therapeutic potentials in cancer. This evidence concerns the gene TGFB1 and cancer.